Gender and age related predictive value of walk test in heart failure: Do anthropometrics matter in clinical practice?

International Journal of Cardiology

Volumn 127, Issue 3, 2008, Pages 331-336

  Frankenstein, L ^a   Remppis, A ^a   Graham, J ^a   Schellberg, D ^a   Sigg, C ^a   Nelles, M ^a   Katus, H A ^a   Zugck, C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Age; Chronic heart failure; Gender; Risk stratification; Walk test

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SPIRONOLACTONE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; WALKING;

ADULT; AGE FACTORS; AGED; ANTHROPOMETRY; BIOMEDICAL RESEARCH; COHORT STUDIES; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEX FACTORS; WALKING;

EID: 46049086392     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.04.087     Document Type: Article

References (35)

1. Demers C., McKelvie R.S., Negassa A., Yusuf S., and RESOLVD Pilot Study Investigators. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 142 (2001) 698-703
2. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132 (1985) 919-923
3. Bittner V., Weiner D.H., Yusuf S., et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 270 (1993) 1702-1707
4. Curtis J.P., Rathore S.S., Wang Y., and Krumholz H.M. The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. J Card Fail 10 (2004) 9-14
5. Roul G., Germain P., and Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?. Am Heart J 136 (1998) 449-457
6. Shah M.R., Hasselblad V., Gheorghiade M., et al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or non-ischemic cardiomyopathy. Am J Cardiol 88 (2001) 987-993
7. Califf R.M., Adams K.F., McKenna W.J., et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J 134 (1997) 44-54
8. Packer M., Colucci W.S., Sackner-Bernstein J.D., et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation 94 (1996) 2793-2799
9. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., and Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
10. Cazeau S., Leclercq C., Lavergne T., et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
11. Abraham W.T., Fisher W.G., Smith A.L., et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
12. Cicoira M., Davos C.H., Francis D.P., et al. Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. J Card Fail 10 (2004) 421-426
13. Adams Jr. K.F., Sueta C.A., Gheorghiade M., et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99 (1999) 1816-1821
14. Rostagno C., Olivo G., Comeglio M., et al. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 5 (2003) 247-252
15. Cahalin L., Pappagianopoulos P., Prevost S., Wain J., and Ginns L. The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest 108 (1995) 452-459
16. Zugck C., Kruger C., Durr S., et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?. Eur Heart J 21 (2000) 540-549
17. Ingle L., Shelton R.J., Rigby A.S., Naab S., Clark A.L., and Cleland J.G. The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure. Eur Heart J 26 (2005) 1742-1751
18. Ingle L., Rigby A.S., Nabb S., Jones P.K., Clark A.L., and Cleland J.G. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. Eur J Heart Fail 8 (2006) 321-325
19. Camarri B., Eastwood P.R., Cecins N.M., Thompson P.J., and Jenkins S. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med 100 (2006) 658-665
20. Chetta A., Zanini A., Pisi G., et al. Reference values for the 6-min walk test in healthy subjects 20-50 years old. Respir Med 100 (2006) 1573-1578
21. Troosters T., Gosselink R., and Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 14 (1999) 270-274
22. Enright P.L., and Sherrill D.L. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 158 (1998) 1384-1387
23. Lissin L.W., Gauri A.J., Froelicher V.F., Ghayoumi A., Myers J., and Giacommini J. The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. J Card Fail 8 (2002) 206-215
24. Davos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003) 29-35
25. Hulens M., Vansant G., Claessens A.L., Lysens R., and Muls E. Predictors of 6-minute walk test results in lean, obese and morbidly obese females. Scand J Med Sci Sports 13 (2003) 98-105
26. Loellgen H. Kardiopulmonale Funktionsdiagnostik. Nuernberg, cardiovascularia. 3rd ed. (2000)
27. Statistisches Bundesamt der Bundesrepublik Deutschland; www.destatis.de/basis/d/gesu/gesutab8.php.
28. Opasich C., Ambrosino N., Felicetti G., et al. Heart failure-related myopathy. Clinical and pathophysiological insights. Eur Heart J 20 (1999) 1191-1200
29. Coats A.J.S. The "muscle hypothesis" of chronic heart failure. J Mol Cell Cardiol 28 (1996) 2255-2262
30. Olsson L.G., Swedberg K., Clark A.L., Witte K.K., and Cleland J.G. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 26 (2005) 778-793
31. Opasich C., Pinna G.D., Mazza A., et al. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?. Eur Heart J 22 (2001) 488-496
32. Akashi Y.J., Springer J., and Anker S.D. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2 (2005) 198-203
33. Wu G., Sanderson B., and Bittner V. The 6-minute walk test: how important is the learning effect?. Am Heart J 146 (2003) 129-133
34. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
35. Guyatt G.H., Pugsley S.O., Sullivan M.J., et al. Effect of encouragement on walking test performance. Thorax 39 (1984) 818-822